Laurion Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Laurion Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-513,972	Closed	-$1.78M	–	674
2023 Q1	$1.78M	Buy	513,972 +18,672	+4%	+$76.2K	0.01%	280
2022 Q4	$1.21M	Hold	495,300	–	–	0.01%	320
2022 Q3	$1.37M	Hold	495,300	–	–	0.01%	353
2022 Q2	$2.02M	Buy	+495,300	New	+$1.57M	0.03%	231

Other funds holding OLMA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Laurion Capital Management's OLMA Position: Q2 2023 in Review

Laurion Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2023, closing a stake of 513,972 shares — an estimated $1.78M sold.

Laurion Capital Management first reported a position in OLMA in Q2 2022 and held it in 4 quarters. The position peaked at $2.02M in Q2 2022. 87 funds tracked by Wall St. Rank hold OLMA as of Q2 2023.

Laurion Capital Management reported no remaining Olema Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Laurion Capital Management sold 513,972 Olema Pharmaceuticals shares in Q2 2023, an estimated $1.78M.
Laurion Capital Management first reported a position in Olema Pharmaceuticals in Q2 2022 and held it in 4 quarters.
Laurion Capital Management's Olema Pharmaceuticals position peaked at $2.02M in Q2 2022.
87 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2023.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.